DARE · Insider Trading
Dare Bioscience, Inc. Common Stock
Every open-market purchase and sale reported by DARE officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-02 | Susan L. Kelley | Director | A | +23,696 | — |
| 2026-07-02 | Robin Joan Steele | Director | A | +26,540 | — |
| 2026-07-02 | Gregory W Matz | Director | A | +30,805 | — |
| 2026-07-02 | William H Rastetter | Director | A | +38,862 | — |
| 2026-07-02 | Jessica D. Grossman | Director | A | +26,066 | — |
| 2026-06-11 | Jessica D. Grossman | Director | A | +10,000 deriv. | — |
| 2026-06-11 | William H Rastetter | Director | A | +10,000 deriv. | — |
| 2026-06-11 | Susan L. Kelley | Director | A | +10,000 deriv. | — |
| 2026-06-11 | Robin Joan Steele | Director | A | +10,000 deriv. | — |
| 2026-06-11 | Gregory W Matz | Director | A | +10,000 deriv. | — |
| 2026-02-20 | Sabrina Martucci Johnson | Chef Executive Officer | A | +32,400 deriv. | — |
| 2026-02-02 | MarDee Haring-Layton | Chief Accounting Officer | A | +49,000 deriv. | — |
| 2026-02-02 | Sabrina Martucci Johnson | Chef Executive Officer | A | +172,000 deriv. | — |
| 2025-09-04 | MarDee Haring-Layton | Chief Accounting Officer | A | +57,000 deriv. | — |
| 2025-07-10 | Robin Joan Steele | Director | A | +4,500 deriv. | — |
| 2025-07-10 | Gregory W Matz | Director | A | +4,500 deriv. | — |
| 2025-07-10 | Susan L. Kelley | Director | A | +4,500 deriv. | — |
| 2025-07-10 | William H Rastetter | Director | A | +4,500 deriv. | — |
| 2025-07-10 | Jessica D. Grossman | Director | A | +4,500 deriv. | — |
| 2025-01-31 | MarDee Haring-Layton | Chief Accounting Officer | A | +38,000 deriv. | — |
| 2025-01-31 | Sabrina Martucci Johnson | Chef Executive Officer | A | +107,000 deriv. | — |
| 2024-06-07 | Susan L. Kelley | Director | A | +40,000 deriv. | — |
| 2024-06-07 | Jessica D. Grossman | Director | A | +40,000 deriv. | — |
| 2024-06-07 | William H Rastetter | Director | A | +40,000 deriv. | — |
| 2024-06-07 | Robin Joan Steele | Director | A | +40,000 deriv. | — |
| 2024-06-07 | Gregory W Matz | Director | A | +40,000 deriv. | — |
| 2024-03-14 | Sabrina Martucci Johnson | Chef Executive Officer | A | +750,000 deriv. | — |
| 2024-03-14 | MarDee Haring-Layton | Chief Accounting Officer | A | +290,000 deriv. | — |
| 2024-03-14 | John A Fair | Chief Commercial Officer | A | +290,000 deriv. | — |
| 2023-06-21 | Sophia Nnenna Ononye-Onyia | Director | A | +40,000 deriv. | — |
| 2023-06-21 | Jessica D. Grossman | Director | A | +40,000 deriv. | — |
| 2023-06-21 | Robin Joan Steele | Director | A | +40,000 deriv. | — |
| 2023-06-21 | Gregory W Matz | Director | A | +40,000 deriv. | — |
| 2023-06-21 | William H Rastetter | Director | A | +40,000 deriv. | — |
| 2023-06-21 | Susan L. Kelley | Director | A | +40,000 deriv. | — |
| 2023-06-21 | Cheryl R Blanchard | Director | A | +40,000 deriv. | — |
| 2023-01-26 | John A Fair | Chief Commercial Officer | A | +290,000 deriv. | — |
| 2023-01-26 | Sabrina Martucci Johnson | Chef Executive Officer | A | +750,000 deriv. | — |
| 2023-01-26 | Lisa Walters-Hoffert | Chief Financial Officer | A | +290,000 deriv. | — |
| 2022-06-24 | William H Rastetter | Director | A | +38,000 deriv. | — |
| 2022-06-24 | Sophia Nnenna Ononye-Onyia | Director | A | +38,000 deriv. | — |
| 2022-06-24 | Jessica D. Grossman | Director | A | +38,000 deriv. | — |
| 2022-06-24 | Gregory W Matz | Director | A | +38,000 deriv. | — |
| 2022-06-24 | Cheryl R Blanchard | Director | A | +38,000 deriv. | — |
| 2022-06-24 | Robin Joan Steele | Director | A | +38,000 deriv. | — |
| 2022-06-24 | Susan L. Kelley | Director | A | +38,000 deriv. | — |
| 2022-01-28 | John A Fair | Chief Strategy Officer | A | +185,000 deriv. | — |
| 2022-01-28 | Sabrina Martucci Johnson | Chef Executive Officer | A | +628,400 deriv. | — |
| 2022-01-28 | Lisa Walters-Hoffert | Chief Financial Officer | A | +185,000 deriv. | — |
| 2021-06-24 | Cheryl R Blanchard | Director | A | +30,000 deriv. | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| Sabrina Martucci Johnson | Chef Executive Officer | 80,172 | $51.61K |
| Robin Joan Steele | Director | 67,569 | $43.50K |
| William H Rastetter | Director | 39,721 | $25.57K |
| Gregory W Matz | Director | 30,847 | $19.86K |
| Jessica D. Grossman | Director | 26,066 | $16.78K |
| Susan L. Kelley | Director | 23,696 | $15.26K |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the DARE quote page; the site-wide leaderboard is on the insider transactions hub.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.